Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis.

Saketkoo LA, Karpinski A, Young J, Adell R, Walker M, Hennebury T, Wickremasinghe M, Russell AM.

ERJ Open Res. 2018 May 8;4(2). pii: 00085-2017. doi: 10.1183/23120541.00085-2017. eCollection 2018 Apr.

2.

Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis.

Eberhardt C, Thillai M, Parker R, Siddiqui N, Potiphar L, Goldin R, Timms JF, Wells AU, Kon OM, Wickremasinghe M, Mitchell D, Weeks ME, Lalvani A.

PLoS One. 2017 Jan 23;12(1):e0170285. doi: 10.1371/journal.pone.0170285. eCollection 2017.

3.

Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.

Singanayagam A, Manalan K, Connell DW, Chalmers JD, Sridhar S, Ritchie AI, Lalvani A, Wickremasinghe M, Kon OM.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1653-1660.

4.

Viral hepatitis prevalence in patients with active and latent tuberculosis.

Nooredinvand HA, Connell DW, Asgheddi M, Abdullah M, O'Donoghue M, Campbell L, Wickremasinghe MI, Lalvani A, Kon OM, Khan SA.

World J Gastroenterol. 2015 Aug 7;21(29):8920-6. doi: 10.3748/wjg.v21.i29.8920.

5.

Screening for latent tuberculosis before tumour necrosis factor antagonist therapy.

Hewitt RJ, Singanayagam A, Sridhar S, Wickremasinghe M, Min Kon O.

Eur Respir J. 2015 May;45(5):1510-2. doi: 10.1183/09031936.00194314. No abstract available.

6.

Letter in response to TB during TNF-α inhibitor therapy, despite screening.

Manalan K, Singanayagam A, Wickremasinghe M, Kon OM.

Thorax. 2015 Apr;70(4):373. doi: 10.1136/thoraxjnl-2014-206239. Epub 2014 Oct 29. No abstract available.

PMID:
25354515
7.

Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound.

Dhasmana DJ, Ross C, Bradley CJ, Connell DW, George PM, Singanayagam A, Jepson A, Craig C, Wright C, Molyneaux PL, Wickremasinghe M, Lalvani A, Cooke GS, Kon OM.

Ann Am Thorac Soc. 2014 Mar;11(3):392-6. doi: 10.1513/AnnalsATS.201308-250OC.

8.

Rituximab in severe, treatment-refractory interstitial lung disease.

Keir GJ, Maher TM, Ming D, Abdullah R, de Lauretis A, Wickremasinghe M, Nicholson AG, Hansell DM, Wells AU, Renzoni EA.

Respirology. 2014 Apr;19(3):353-9. doi: 10.1111/resp.12214. Epub 2013 Nov 29.

9.

Importance of onsite cytopathology at endobronchial ultrasound.

Honor Craig CE, Wickremasinghe M, Finney L, Wright CB, Berry M, Kon OM.

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1164. doi: 10.1164/rccm.201302-0378LE. No abstract available.

PMID:
24180447
10.

Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy.

Singanayagam A, Manalan K, Sridhar S, Molyneaux PL, Connell DW, George PM, Kindelerer A, Seneviratne S, Lalvani A, Wickremasinghe M, Kon OM.

Thorax. 2013 Oct;68(10):955-61. doi: 10.1136/thoraxjnl-2013-203436. Epub 2013 Aug 23.

11.

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

Bloom CI, Graham CM, Berry MP, Rozakeas F, Redford PS, Wang Y, Xu Z, Wilkinson KA, Wilkinson RJ, Kendrick Y, Devouassoux G, Ferry T, Miyara M, Bouvry D, Valeyre D, Gorochov G, Blankenship D, Saadatian M, Vanhems P, Beynon H, Vancheeswaran R, Wickremasinghe M, Chaussabel D, Banchereau J, Pascual V, Ho LP, Lipman M, O'Garra A.

PLoS One. 2013 Aug 5;8(8):e70630. doi: 10.1371/journal.pone.0070630. Print 2013. Erratum in: PLoS One. 2013;8(8).doi: 10.1371/annotation/7d9ec449-aee0-48fe-8111-0c110850c0c1. Dominique, Valeyre [corrected to Valeyre, Dominique].

12.

Primary nodal anthracosis identified by EBUS-TBNA as a cause of FDG PET/CT positive mediastinal lymphadenopathy.

Hewitt RJ, Wright C, Adeboyeku D, Ornadel D, Berry M, Wickremasinghe M, Wright A, Sykes A, Kon OM.

Respir Med Case Rep. 2013 Sep 27;10:48-52. doi: 10.1016/j.rmcr.2013.09.005. eCollection 2013.

13.

Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood.

Thillai M, Eberhardt C, Lewin AM, Potiphar L, Hingley-Wilson S, Sridhar S, Macintyre J, Kon OM, Wickremasinghe M, Wells A, Weeks ME, Mitchell D, Lalvani A.

PLoS One. 2012;7(7):e38083. doi: 10.1371/journal.pone.0038083. Epub 2012 Jul 16.

14.

Obstructive lung function in sarcoidosis may be missed, especially in older white patients.

Thillai M, Potiphar L, Eberhardt C, Pareek M, Dhawan R, Kon OM, Wickremasinghe M, Wells A, Mitchell D, Lalvani A.

Eur Respir J. 2012 Mar;39(3):775-7. doi: 10.1183/09031936.00103811. No abstract available.

15.

A comparison between two strategies for monitoring hepatic function during antituberculous therapy.

Singanayagam A, Sridhar S, Dhariwal J, Abdel-Aziz D, Munro K, Connell DW, George PM, Molyneaux PL, Cooke GS, Burroughs AK, Lalvani A, Wickremasinghe M, Kon OM.

Am J Respir Crit Care Med. 2012 Mar 15;185(6):653-9. doi: 10.1164/rccm.201105-0850OC. Epub 2011 Dec 28.

PMID:
22198973
16.

Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB.

George PM, Mehta M, Dhariwal J, Singanayagam A, Raphael CE, Salmasi M, Connell DW, Molyneaux P, Wickremasinghe M, Jepson A, Kon OM.

Respir Med. 2011 Nov;105(11):1726-31. doi: 10.1016/j.rmed.2011.07.014. Epub 2011 Aug 15.

17.

Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study.

Navani N, Molyneaux PL, Breen RA, Connell DW, Jepson A, Nankivell M, Brown JM, Morris-Jones S, Ng B, Wickremasinghe M, Lalvani A, Rintoul RC, Santis G, Kon OM, Janes SM.

Thorax. 2011 Oct;66(10):889-93. doi: 10.1136/thoraxjnl-2011-200063. Epub 2011 Aug 3.

18.

Thrombotic microangiopathy complicating pegylated interferon treatment of hepatitis C infection.

Iskander D, Wickremasinghe M, Bain BJ.

Am J Hematol. 2011 Oct;86(10):859. doi: 10.1002/ajh.22057. Epub 2011 May 31. No abstract available.

19.

Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection.

Millington KA, Fortune SM, Low J, Garces A, Hingley-Wilson SM, Wickremasinghe M, Kon OM, Lalvani A.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5730-5. doi: 10.1073/pnas.1015153108. Epub 2011 Mar 22.

20.

Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis.

Casey R, Blumenkrantz D, Millington K, Montamat-Sicotte D, Kon OM, Wickremasinghe M, Bremang S, Magtoto M, Sridhar S, Connell D, Lalvani A.

PLoS One. 2010 Dec 14;5(12):e15619. doi: 10.1371/journal.pone.0015619.

21.

The use of thoracic computed tomography scanning and EBUS-TBNA to diagnose tuberculosis of the central nervous system: two case reports.

Mehta MR, Connell DW, Wickremasinghe MI, Kon OM.

Eur Respir Rev. 2010 Dec;19(118):345-7. doi: 10.1183/09059180.00002910.

22.

Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction.

Bloch S, Wickremasinghe M, Wright A, Rice A, Thompson M, Kon OM.

Eur Respir Rev. 2009 Dec;18(114):295-9. doi: 10.1183/09059180.00003709.

23.

IL-1 beta stimulates divergent upper and lower airway epithelial cell CCL5 secretion.

Thomas LH, Wickremasinghe MI, Friedland JS.

Clin Immunol. 2007 Feb;122(2):229-38. Epub 2006 Nov 22.

PMID:
17126080
24.

Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis.

Kunst H, Wickremasinghe M, Wells A, Wilson R.

Eur Respir J. 2006 Aug;28(2):352-7. Epub 2006 Apr 12.

25.

Non-tuberculous mycobacteria in patients with bronchiectasis.

Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV, Abdallah S, Shah P, Wilson R.

Thorax. 2005 Dec;60(12):1045-51. Epub 2005 Oct 14.

26.

Transcriptional mechanisms regulating alveolar epithelial cell-specific CCL5 secretion in pulmonary tuberculosis.

Wickremasinghe MI, Thomas LH, O'Kane CM, Uddin J, Friedland JS.

J Biol Chem. 2004 Jun 25;279(26):27199-210. Epub 2004 Apr 26.

29.

Attenuation of propranolol-induced bronchoconstriction by frusemide.

Myers JD, Higham MA, Shakur BH, Wickremasinghe M, Ind PW.

Thorax. 1997 Oct;52(10):861-5.

30.

Respiratory conditions associated with haematological malignancies.

Wickremasinghe M.

Thorax. 1997 Apr;52(4):390-1. No abstract available.

31.

Commentary. Ecstasy and crack cocaine.

Wickremasinghe M.

Thorax. 1996 Sep;51(9):962-3. No abstract available.

Supplemental Content

Loading ...
Support Center